The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Vemurafenib-associated bullous DRESS syndrome: A very severe cutaneous reaction.
Aurelia Gey
No relevant relationships to disclose
Thomas Jouary
No relevant relationships to disclose
Christine Mateus
No relevant relationships to disclose
Caroline Robert
No relevant relationships to disclose
Gerard Perro
No relevant relationships to disclose
Brigitte Milpied
No relevant relationships to disclose